- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
Exhibit 15.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Shareholders of GW Pharmaceuticals plc
We consent to the incorporation by reference in Registration Statement No. 333-195747 on Form F-3 of our reports dated 2 December 2014, relating to the consolidated financial statements of GW Pharmaceuticals plc, and the effectiveness of GW Pharmaceuticals plc’s internal control over financial reporting (which report expresses an adverse opinion on the effectiveness of GW Pharmaceuticals plc’s internal control over financial reporting because of a material weakness), appearing in this Annual Report on Form 20-F of GW Pharmaceuticals plc for the year ended 30 September 2014.
/s/ Deloitte LLP
Reading, United Kingdom
2 December 2014